Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
11h
Pharmaceutical Technology on MSNRelmada acquires Tourette’s therapy rights from AsarinaRelmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
2d
GlobalData on MSNAlys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trialAlys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...
2d
Vietnam Investment Review on MSNStimulating year ahead for pharmaVietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...
Yokogawa Electric Corporation has announced the release of OpreX Quality Management System, a product in the OpreX ...
CN Water is a leading water treatment solution provider with over 150 clients across industries and 700 operational plants ...
Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...
Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results